Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
VivoSim Labs ( (VIVS) ) has shared an update.
At its 2025 Annual Meeting of Stockholders held on December 16, 2025, VivoSim Labs, Inc. reported that 37.29% of its outstanding common shares were represented, satisfying quorum requirements and enabling the company to conduct formal corporate governance business, including director elections and advisory votes on executive pay practices. Stockholders elected Douglas Jay Cohen and David Gobel as Class II directors to serve until the 2028 annual meeting, ratified Rosenberg Rich Baker Berman P.A. as independent auditor for the fiscal year ending March 31, 2026 with 97.91% support, approved on a non-binding basis the compensation of named executive officers with 89.97% support, and strongly backed an annual (“one year”) frequency for future advisory votes on executive compensation, which the company has adopted as its policy; no other items were brought for stockholder approval, underscoring continuity in board composition, auditor engagement, and say‑on‑pay governance practices.
More about VivoSim Labs
VivoSim Labs, Inc. is a publicly traded company whose common stock is held by a dispersed base of stockholders and governed through an annual meeting process, with an established board structure using classified director terms and engagement with an independent registered public accounting firm.
Average Trading Volume: 489,997
Technical Sentiment Signal: Sell
Current Market Cap: $5.19M
For detailed information about VIVS stock, go to TipRanks’ Stock Analysis page.